ProShare Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-18,385
Closed -$70K 1693
2020
Q1
$70K Sell
18,385
-14,467
-44% -$55.1K ﹤0.01% 1102
2019
Q4
$167K Sell
32,852
-2,633
-7% -$13.4K ﹤0.01% 1632
2019
Q3
$179K Sell
35,485
-615
-2% -$3.1K ﹤0.01% 1464
2019
Q2
$223K Sell
36,100
-4,227
-10% -$26.1K ﹤0.01% 1381
2019
Q1
$187K Buy
40,327
+408
+1% +$1.89K ﹤0.01% 1489
2018
Q4
$168K Sell
39,919
-6,959
-15% -$29.3K ﹤0.01% 1407
2018
Q3
$294K Buy
46,878
+3,747
+9% +$23.5K ﹤0.01% 1372
2018
Q2
$347K Sell
43,131
-578
-1% -$4.65K ﹤0.01% 1297
2018
Q1
$326K Sell
43,709
-6,787
-13% -$50.6K ﹤0.01% 1278
2017
Q4
$300K Buy
50,496
+4,686
+10% +$27.8K ﹤0.01% 1388
2017
Q3
$337K Buy
45,810
+2,467
+6% +$18.1K ﹤0.01% 1098
2017
Q2
$294K Sell
43,343
-3,688
-8% -$25K ﹤0.01% 1178
2017
Q1
$444K Sell
47,031
-10,428
-18% -$98.4K ﹤0.01% 1046
2016
Q4
$496K Buy
57,459
+6,445
+13% +$55.6K 0.01% 1085
2016
Q3
$323K Sell
51,014
-9,572
-16% -$60.6K ﹤0.01% 1119
2016
Q2
$256K Buy
60,586
+387
+0.6% +$1.64K ﹤0.01% 1284
2016
Q1
$262K Sell
60,199
-6,077
-9% -$26.4K ﹤0.01% 1271
2015
Q4
$406K Buy
66,276
+6,481
+11% +$39.7K ﹤0.01% 1136
2015
Q3
$342K Sell
59,795
-4,641
-7% -$26.5K ﹤0.01% 1095
2015
Q2
$481K Sell
64,436
-5,042
-7% -$37.6K 0.01% 1114
2015
Q1
$415K Buy
69,478
+8,706
+14% +$52K ﹤0.01% 1278
2014
Q4
$459K Sell
60,772
-2,450
-4% -$18.5K 0.01% 1247
2014
Q3
$328K Sell
63,222
-12,588
-17% -$65.3K ﹤0.01% 1661
2014
Q2
$327K Sell
75,810
-45,842
-38% -$198K ﹤0.01% 1847
2014
Q1
$498K Buy
121,652
+90,492
+290% +$370K 0.01% 1874
2013
Q4
$166K Sell
31,160
-27,855
-47% -$148K ﹤0.01% 1272
2013
Q3
$297K Buy
59,015
+19,563
+50% +$98.5K 0.01% 1907
2013
Q2
$176K Buy
+39,452
New +$176K ﹤0.01% 2088